EN | DE

In the News

SHARE THIS PAGE:

Barricaid at 5th BioSpine: Only option to close large anular defects

April 08, 2015

BioSpine is the leading international symposium on regenerative spinal technologies, acting as a catalyst between clinicians, scientists and industrial partners to support information exchange on biological solutions

This bi-annual event took place on 8-11 April in Berlin and featured a first-time dedicated scientific session on the “Treatment of Anulus Fibrosus Defects”. The biomechanical performance and clinical results of Barricaid® Anular Closure were discussed in detail. One of the conclusions to draw from this session is that Barricaid® currently is the only viable, clinically evaluated option for closing large anular defects.

GO BACK

biospine-barricaid